Connect with us

NEWS

It Turns Out, Marjorie Taylor Greene Owns Stock In 3 Vaccine Manufacturers

Published

on

Marjorie Taylor Greene

It turns out, GOP Rep. and vaccine critic Marjorie Taylor Greene owns stock in three different COVID-19 vaccine makers during 2020, the Chattanooga Times Free Press reported, citing financial disclosures the Georgia lawmaker submitted this year.

“Greene, who has been critical of vaccine mandates since the start of the pandemic and last month told a town hall she was not vaccinated, held the investments in the companies as Congress was determining how best to manage pandemic relief efforts. Trillions of dollars were funneled into COVID relief bills in 2020 and 2021, including several billion to help drug companies develop, produce and distribute vaccines,” journalist Kelcey Caulder wrote in the report.

According to the news outlet, Greene owns stock in Pfizer, AstraZeneca and Johnson & Johnson.

The disclosure filed in August shows that her assets in AstraZeneca are valued between $1,001-$15,000, while her assets in Pfizer and Johnson & Johnson are each valued between $15,001-$50,000.

Jennifer Strahan, a Georgia businesswoman who announced her plans to run against Greene in the Republican primary in October, was among the first to draw attention to Greene’s investments in a Twitter poll posted earlier this week. She asked readers to choose which of three vaccine companies Greene owns stock in, then left an option for “all of the above.”

“Our district deserves someone who is honest and practices what they preach. I know I am not the only one who is surprised to find Rep. Greene owns stock in three of the four major vaccine manufacturing companies despite her open disdain for the vaccine,” Strahan said in a statement to the Times Free Press on Friday. “She simply is not who she tells Georgians she is, and this is just the latest example.”

Read more here.